| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.6M | -18.9% |
| SG&A Expense | $5.2M | +2.5% |
| Operating Income | -$7.8M | +5.9% |
| Pre-tax Income | -$8.0M | +39.6% |
| Net Income | -$8.0M | +39.6% |
| EPS (Basic) | -$11.93 | -338.6% |
| EPS (Diluted) | -$11.93 | -338.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.9M | +56.8% |
| Current Assets | $6.2M | +52.3% |
| Total Assets | $6.7M | +32.3% |
| Current Liabilities | $1.4M | +43.1% |
| Total Liabilities | $1.4M | +43.1% |
| Stockholders' Equity | $5.3M | +29.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.5M | +6.2% |
| Investing Cash Flow | $150K | — |
| Financing Cash Flow | $8.5M | +8.0% |